Showing 61-75 of 546
-
Invited Perspective. Per- and Polyfluoroalkyl Substances, Hepatotoxicity, and Liver Disease: Evidence and Clinical Responses
Science
25 Dec 2023 | Medical Research Archives
This perspective outlines PFAS hepatoxicity, suggesting practical clinician responses to address patient and community needs, and emphasizing strong evidence of PFAS causing adverse changes in human liver biomarkers.
-
Firefighters' exposure to per-and polyfluoroalkyl substances (PFAS) as an occupational hazard: A review.
Science
18 Dec 2023 | Front Mater
The close link between firefighters and cancer may be partly driven by occupational exposure to carcinogenic PFAS found in turnout gear, firefighting foam, and fire station environments leading to elevated PFAS levels in firefighters’ blood serum.
-
First insights into per-and polyfluoroalkyl substance contamination in edible fish species of the Indus water system of Pakistan
Science
17 Dec 2023 | Chemosphere
The study investigated the contamination of edible fish in major tributaries of the Indus System andfound high levels of PFAS, in certain fish species from areas with poor wastewater treatment in Pakistan, highlighting potential environmental and health concerns, and suggesting the need for ongoing monitoring and research into the bioaccumulation patterns of PFAS.
-
Associations of a Prenatal Serum Per- and Polyfluoroalkyl Substance Mixture with the Cord Serum Metabolome in the HOME Study
Science
13 Dec 2023 | Environ Sci Technol
Prenatal exposure to a mixture of PFAS in mothers is linked to alterations in infant metabolic pathways, which can result in birthweight or vaccine response abnormalities.
-
[Press Release] Kildee Introduces New Bipartisan Legislation To Improve Medical Treatment For PFAS-Exposed Patients
Policy
7 Dec 2023
Congressman Dan Kildee, co-chair of the bipartisan Congressional PFAS Task Force, and Congressman Mike Lawler today introduced bipartisan legislation, supported by Republicans and Democrats, to ensure doctors have up-to-date information on how best to treat patients exposed to toxic PFAS.
-
Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva
Science
6 Dec 2023 | Environ Health Perspect
Prenatal exposure to PFAS impacted the body weight and composition of teenagers, finding that higher concentrations of these substances were associated with an increased risk of obesity and altered BMI trajectories during late adolescence.
-
Prenatal exposure to per- and polyfluoroalkyl substances and early childhood adiposity and cardiometabolic health in the Healthy Start study
Science
2 Dec 2023 | IJO
Exposure to PFAS during pregnancy was found to be associated with increased body mass in early childhood, particularly in terms of precisely measured fat mass, emphasizing potential health implications for children exposed to PFAS during gestation.
-
Prenatal exposure to Per-and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China
Science
1 Dec 2023 | Ecotoxicol Environ Saf
Exposure to PFAS during pregnancy was linked to increased adiposity in Chinese children at ages 4 and 6, with a stronger impact on measures like arm circumference and waist circumference, particularly among girls.
-
Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid
Science
30 Nov 2023 | Lancet Onc.
A Working Group of 30 scientists from 11 countries met at the International Agency for Research on Cancer in Lyon, France, to finalise their evaluation of the carcinogenicity of two agents: PFOA and PFOS, including their corresponding isomers and salts.
-
Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study
Science
23 Nov 2023 | Environ Res
Exposure to PFOS was found to be associated with lower bone mineral density in both Hispanic adolescents and mixed-ethnicity young adults, suggesting potential long-term impacts on bone health and increased risk of osteoporosis in adulthood.
-
PFAS and WHO: Major Conference This Week Will Impact Litigation
Policy
10 Nov 2023
This week, the International Agency For Research On Cancer is holding a week-long conference in Lyon, France to discuss the carcinogenicity of PFOA and PFAS.
-
Exposure to perfluoroalkyl and polyfluoroalkyl substances and pediatric obesity: a systematic review and meta-analysis
Science
31 Oct 2023 | Int J Obes (Lond)
The review investigated the potential impact of PFAS on childhood obesity. It observed a possible inverse relationship between postnatal PFAS exposure and changes in body mass index though the review was limited by the small number of studies.
-
Trends in Serum Per-and Polyfluoroalkyl Substance (PFAS) Concentrations in Teenagers and Adults, 1999–2018 NHANES
Science
27 Oct 2023 | Int. J. Environ. Res. Public Health
Some longer chain PFAS levels in serum have decreased over time, however they are still detected in drinking water and consumer products, with certain racial/ethnic groups showing differing levels of exposure, highlighting the need for continued monitoring.
-
Perfluoroalkyl substances in umbilical cord blood and blood pressure in offspring: a prospective cohort study
Science
19 Oct 2023 | Environmental Health
Exposure to certain long-chain PFAS, particularly PFOS, PFDA, and PFUA, in umbilical cord blood was associated with lower blood pressure in offspring at the age of 4 years, with PFUA being the most significant contributor and PFDoA exhibiting a positive association with blood pressure.
-
Prenatal Exposure to Multiple Endocrine-Disrupting Chemicals and Childhood BMI Trajectories in the INMA Cohort Study
Science
18 Oct 2023 | Environ Health Perspect
Exposure to HCB, DDE, PCBs, and PFNA was linked to an increased risk of lower birth size followed by accelerated BMI gain in single-exposure models.